. doi: 10.1016/j.virs.2025.07.003
Citation: Lu Yang, Linhua Wang, Qian Liu, Xu Zhang, Yuexin Luo, Junbiao Xue, Xinpu Yang, Maria G. Byazrova, Alexander V. Filatov, Sheng-Ce Tao, Wei Xiao, Chaohong Liu. STAT5-c-Myc-axis regulates B cell metabolism in vaccinated individuals and COVID-19 recovered patients .VIROLOGICA SINICA, 2025, 40(4) : 571-578.  http://dx.doi.org/10.1016/j.virs.2025.07.003

STAT5-c-Myc-axis regulates B cell metabolism in vaccinated individuals and COVID-19 recovered patients

  • SARS-CoV-2 感染和疫苗接种都会触发免疫反应。前者导致自然获得性免疫,而后者通过人工方式诱导主动免疫。然而,疫苗接种和感染的不同免疫效应及其潜在机制需要进一步阐明。在本研究中,我们比较了接种疫苗组和康复组的外周 B 细胞分化、血清学差异和 BCR 信号分子的表达。接种疫苗组表现出 RBD 特异性 B 细胞分化降低和 记忆B细胞表面CD86 信号强度降低,但 B 细胞中 BCR 信号增强。在代谢信号传导方面,接种疫苗组B细胞中 pS6 、 c-Myc 、 pmTOR 和 pSTAT5 的表达水平升高,提示 STAT5-c-Myc 轴在调节 B 细胞代谢中发挥作用。此外,蛋白质组微阵列分析显示,接种疫苗组的血清中含有更高水平的SARS-CoV-2 N-Nter 蛋白特异性 的IgG 抗体和针对 SARS-CoV-2 S1 蛋白特异性的 IgA 抗体。总之,这些发现表明,与康复组相比,接种疫苗组产生了更强大的冠状病毒特异性免疫反应,BCR 信号传导和代谢活性增强。这些见解有助于优化 SARS-CoV-2 疫苗设计。

STAT5-c-Myc-axis regulates B cell metabolism in vaccinated individuals and COVID-19 recovered patients

  • SARS-CoV-2 infection and vaccination both trigger immune responses. The former leads to naturally acquired immunity, while the latter induces active immunity through artificial means. However, the distinct immune effects of vaccination and infection, as well as their underlying mechanisms, require further clarification. In this study, we compared the peripheral B cell differentiation, serological differences and the expression level of BCR signaling molecules between the vaccinated and recovered group. The vaccinated group exhibited reduced RBD-specific B cell differentiation and lower CD86 signal intensity on memory B cells, but enhanced BCR signaling in B cells. Regarding metabolic signaling, the vaccinated group had elevated expression levels of pS6, c-Myc, pmTOR, and pSTAT5, suggesting that the STAT5-c-Myc axis plays a role in regulating B cell metabolism. Additionally, proteome microarray analysis revealed that the serum of the vaccinated group contained higher levels of IgG antibodies against the SARS-CoV-2 N-Nter protein and IgA antibodies specific to the SARS-CoV-2 S1 protein. In summary, these findings indicate that the vaccinated group develops a more robust coronavirus-specific immune response, with enhanced BCR signaling and metabolic activity compared to the recovered group. These insights might contribute to the optimization of SARS-CoV-2 vaccine design.

  • 加载中
    1. Abayasingam, A., Balachandran, H., Agapiou, D., Hammoud, M., Rodrigo, C., Keoshkerian, E., Li, H., Brasher, N.A., Christ, D., Rouet, R., Burnet, D., Grubor-Bauk, B., Rawlinson, W., Turville, S., Aggarwal, A., Stella, A.O., Fichter, C., Brilot, F., Mina, M., Post, J.J., Hudson, B., Gilroy, N., Dwyer, D., Sasson, S.C., Tea, F., Pilli, D., Kelleher, A., Tedla, N., Lloyd, A.R., Martinello, M., Bull, R.A.; COSIN Study Group, 2021. Long-term persistence of RBD(+) memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection. Cell Rep Med, 2, 100228.

    2. Altarawneh, H.N., Chemaitelly, H., Ayoub, H.H., Tang, P., Hasan, M.R., Yassine, H.M., Al-Khatib, H.A., Smatti, M.K., Coyle, P., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A.H., Latif, A.N., Shaik, R.M., Abdul-Rahim, H.F., Nasrallah, G.K., Al-Kuwari, M.G., Butt, A.A., Al-Romaihi, H.E., Al-Thani, M.H., Al-Khal, A., Bertollini, R., Abu-Raddad, L.J., 2022. Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections. N Engl J Med, 387, 21-34.

    3. Appelberg, S., Gupta, S., Svensson Akusjarvi, S., Ambikan, A.T., Mikaeloff, F., Saccon, E., Vegvari, A., Benfeitas, R., Sperk, M., Stahlberg, M., Krishnan, S., Singh, K., Penninger, J.M., Mirazimi, A., Neogi, U., 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect, 9, 1748-1760.

    4. Bi, X., Liu, W., Ding, X., Liang, S., Zheng, Y., Zhu, X., Quan, S., Yi, X., Xiang, N., Du, J., Lyu, H., Yu, D., Zhang, C., Xu, L., Ge, W., Zhan, X., He, J., Xiong, Z., Zhang, S., Li, Y., Xu, P., Zhu, G., Wang, D., Zhu, H., Chen, S., Li, J., Zhao, H., Zhu, Y., Liu, H., Xu, J., Shen, B., Guo, T., 2022. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep, 38, 110271.

    5. Bobrovitz, N., Ware, H., Ma, X., Li, Z., Hosseini, R., Cao, C., Selemon, A., Whelan, M., Premji, Z., Issa, H., Cheng, B., Abu Raddad, L.J., Buckeridge, D.L., Van Kerkhove, M.D., Piechotta, V., Higdon, M.M., Wilder-Smith, A., Bergeri, I., Feikin, D.R., Arora, R.K., Patel, M.K., Subissi, L., 2023. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis, 23, 556-567.

    6. Castro Dopico, X., Ols, S., Lore, K., Karlsson Hedestam, G.B., 2022. Immunity to SARS-CoV-2 induced by infection or vaccination. J Intern Med, 291, 32-50.

    7. Chacko, G.W., Tridandapani, S., Damen, J.E., Liu, L., Krystal, G., Coggeshall, K.M., 1996. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. J Immunol, 157, 2234-2238.

    8. Cheong, J.G., Ravishankar, A., Sharma, S., Parkhurst, C.N., Grassmann, S.A., Wingert, C.K., Laurent, P., Ma, S., Paddock, L., Miranda, I.C., Karakaslar, E.O., Nehar-Belaid, D., Thibodeau, A., Bale, M.J., Kartha, V.K., Yee, J.K., Mays, M.Y., Jiang, C., Daman, A.W., Martinez de Paz, A., Ahimovic, D., Ramos, V., Lercher, A., Nielsen, E., Alvarez-Mulett, S., Zheng, L., Earl, A., Yallowitz, A., Robbins, L., LaFond, E., Weidman, K.L., Racine-Brzostek, S., Yang, H.S., Price, D.R., Leyre, L., Rendeiro, A.F., Ravichandran, H., Kim, J., Borczuk, A.C., Rice, C.M., Jones, R.B., Schenck, E.J., Kaner, R.J., Chadburn, A., Zhao, Z., Pascual, V., Elemento, O., Schwartz, R.E., Buenrostro, J.D., Niec, R.E., Barrat, F.J., Lief, L., Sun, J.C., Ucar, D., Josefowicz, S.Z., 2023. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell, 186, 3882-3902.e3824.

    9. Cyster, J.G., Goodnow, C.C., 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity, 2, 13-24.

    10. Fu, C., Turck, C.W., Kurosaki, T., Chan, A.C., 1998. BLNK: a central linker protein in B cell activation. Immunity, 9, 93-103.

    11. Hashimoto, S., Iwamatsu, A., Ishiai, M., Okawa, K., Yamadori, T., Matsushita, M., Baba, Y., Kishimoto, T., Kurosaki, T., Tsukada, S., 1999. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood, 94, 2357-2364.

    12. He, B., Liu, S., Xu, M., Hu, Y., Lv, K., Wang, Y., Ma, Y., Zhai, Y., Yue, X., Liu, L., Lu, H., Zhou, S., Li, P., Mai, G., Huang, X., Li, C., Chen, S., Ye, S., Zhao, P., Yang, Y., Li, X., Jie, Y., Shi, M., Yang, J., Shu, Y., Chen, Y.Q., 2022. Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing. Emerg Microbes Infect, 11, 2007-2020.

    13. Huang, J., Huang, L., Xi, J., Li, Y., Zhou, J., Bao, Z., Cheng, Q., Li, Q., Zhou, M., Zhao, R., Li, Y., 2023. Risk of extended viral shedding of Omicron BA.2 in Shanghai: Implications for vaccination strategy optimization. Chinese Medical Journal Pulmonary and Critical Care Medicine, 1, 241-248.

    14. Jiang, H.W., Li, Y., Zhang, H.N., Wang, W., Yang, X., Qi, H., Li, H., Men, D., Zhou, J., Tao, S.C., 2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses. Nat Commun, 11, 3581.

    15. Krammer, F., 2020. SARS-CoV-2 vaccines in development. Nature, 586, 516-527.

    16. Li, F., Li, J., Wang, P.H., Yang, N., Huang, J., Ou, J., Xu, T., Zhao, X., Liu, T., Huang, X., Wang, Q., Li, M., Yang, L., Lin, Y., Cai, Y., Chen, H., Zhang, Q., 2021. SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim Biophys Acta Mol Basis Dis, 1867, 166260.

    17. Liu, Y., Gu, X., Li, H., Zhang, H., Xu, J., 2023. Mechanisms of long COVID: An updated review. Chin Med J Pulm Crit Care Med, 1, 231-240.

    18. Niiro, H., Clark, E.A., 2002. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol, 2, 945-956.

    19. Sen Chaudhuri, A., Sun, J., 2024. Lung-resident lymphocytes and their roles in respiratory infections and chronic respiratory diseases. Chin Med J Pulm Crit Care Med, 2, 214-223.

    20. Tregoning, J.S., Flight, K.E., Higham, S.L., Wang, Z., Pierce, B.F., 2021. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol, 21, 626-636.

    21. Villarino, A.V., Laurence, A.D., Davis, F.P., Nivelo, L., Brooks, S.R., Sun, H.W., Jiang, K., Afzali, B., Frasca, D., Hennighausen, L., Kanno, Y., O'shea, J.J., 2022. A central role for STAT5 in the transcriptional programing of T helper cell metabolism. Sci Immunol, 7, eabl9467.

    22. Wang, C., Hao, X., Chen, S., 2023. Calling for improved pulmonary and critical care medicine in China and beyond. Chinese Medical Journal Pulmonary and Critical Care Medicine, 1, 1-2.

    23. Zhang, Z., Mateus, J., Coelho, C.H., Dan, J.M., Moderbacher, C.R., Galvez, R.I., Cortes, F.H., Grifoni, A., Tarke, A., Chang, J., Escarrega, E.A., Kim, C., Goodwin, B., Bloom, N.I., Frazier, A., Weiskopf, D., Sette, A., Crotty, S., 2022. Humoral and cellular immune memory to four COVID-19 vaccines. Cell, 185, 2434-2451.e2417.

    24. Zheng, Z., Peng, F., Zhou, Y., 2023. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? Chin Med J Pulm Crit Care Med, 1, 77-83.

  • 加载中

Figures(1)

Article Metrics

Article views(4781) PDF downloads(19) Cited by(0)

Related
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    STAT5-c-Myc-axis regulates B cell metabolism in vaccinated individuals and COVID-19 recovered patients

      Corresponding author: Lu Yang, yanglu5266@126.com
      Corresponding author: Wei Xiao, 99xw@sina.com
      Corresponding author: Chaohong Liu, chaohongliu80@126.com
    • a. Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, China;
    • b. Department of Immunology, Yangtze University Health Science Center, Yangtze University, Jingzhou, 434023, China;
    • c. Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Yangtze University/The First People's Hospital of Jingzhou, Jingzhou, 434007, China;
    • d. Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200240, China;
    • e. National Research Center Institute of Immunology, Federal Medical Biological Agency of Russia, Moscow, 115522, Russia;
    • f. Department of Immunology, Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia

    Abstract: SARS-CoV-2 infection and vaccination both trigger immune responses. The former leads to naturally acquired immunity, while the latter induces active immunity through artificial means. However, the distinct immune effects of vaccination and infection, as well as their underlying mechanisms, require further clarification. In this study, we compared the peripheral B cell differentiation, serological differences and the expression level of BCR signaling molecules between the vaccinated and recovered group. The vaccinated group exhibited reduced RBD-specific B cell differentiation and lower CD86 signal intensity on memory B cells, but enhanced BCR signaling in B cells. Regarding metabolic signaling, the vaccinated group had elevated expression levels of pS6, c-Myc, pmTOR, and pSTAT5, suggesting that the STAT5-c-Myc axis plays a role in regulating B cell metabolism. Additionally, proteome microarray analysis revealed that the serum of the vaccinated group contained higher levels of IgG antibodies against the SARS-CoV-2 N-Nter protein and IgA antibodies specific to the SARS-CoV-2 S1 protein. In summary, these findings indicate that the vaccinated group develops a more robust coronavirus-specific immune response, with enhanced BCR signaling and metabolic activity compared to the recovered group. These insights might contribute to the optimization of SARS-CoV-2 vaccine design.

    Figure (1)  Reference (24) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return